A Randomized Feasibility Study Evaluating Temozolomide Chronotherapy for High Grade Glioma
Phase of Trial: Phase I
Latest Information Update: 01 Jun 2017
At a glance
- Drugs Temozolomide (Primary)
- Indications Glioblastoma; Glioma
- Focus Therapeutic Use
- 13 Feb 2017 Phase has changed from phase 0 to phase 1 hence protocol amended.
- 12 Aug 2016 Status changed from not yet recruiting to recruiting.
- 08 Jun 2016 New trial record